NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.6840
-0.0183 (-2.61%)
At close: Jul 17, 2026, 4:00 PM EDT
0.7290
+0.0450 (6.58%)
After-hours: Jul 17, 2026, 4:19 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $24.18 million as of July 17, 2026. Its market cap has decreased by -50.35% in one year.
Market Cap
24.18M
Enterprise Value
24.18M
1-Year Change
-50.35%
Ranking
Category
Stock Price
$0.68
ChartMarket Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $24.18M, a decrease of -62.58%. That is a compound annual growth rate of -19.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 24.18M | 5.87% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 26.02M |
| Plus Therapeutics | 25.74M |
| Evaxion | 25.65M |
| GridAI Technologies | 25.41M |
| VYNE Therapeutics | 25.38M |
| Polyrizon | 25.12M |
| Jasper Therapeutics | 24.78M |
| Skye Bioscience | 22.82M |